Carmignac Gestion’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Hold |
1,508,342
| – | – | 0.02% | 104 |
|
|
2025
Q1 | $1.38M | Sell |
1,508,342
-425,189
| -22% | -$390K | 0.02% | 118 |
|
|
2024
Q4 | $1.84M | Hold |
1,933,531
| – | – | 0.03% | 102 |
|
|
2024
Q3 | $2.46M | Sell |
1,933,531
-199,213
| -9% | -$253K | 0.04% | 108 |
|
|
2024
Q2 | $2.77M | Hold |
2,132,744
| – | – | 0.05% | 97 |
|
|
2024
Q1 | $3.26M | Hold |
2,132,744
| – | – | 0.05% | 83 |
|
|
2023
Q4 | $2.5M | Hold |
2,132,744
| – | – | 0.04% | 99 |
|
|
2023
Q3 | $1.86M | Sell |
2,132,744
-267,600
| -11% | -$233K | 0.03% | 104 |
|
|
2023
Q2 | $2.69M | Hold |
2,400,344
| – | – | 0.05% | 95 |
|
|
2023
Q1 | $2.5M | Hold |
2,400,344
| – | – | 0.04% | 86 |
|
|
2022
Q4 | $2.69M | Hold |
2,400,344
| – | – | 0.05% | 84 |
|
|
2022
Q3 | $2.71M | Buy |
2,400,344
+10,000
| +0.4% | +$11.3K | 0.06% | 70 |
|
|
2022
Q2 | $3.51M | Sell |
2,390,344
-95,308
| -4% | -$140K | 0.07% | 72 |
|
|
2022
Q1 | $5.69M | Hold |
2,485,652
| – | – | 0.09% | 67 |
|
|
2021
Q4 | $6.84M | Buy |
2,485,652
+10,000
| +0.4% | +$27.5K | 0.1% | 79 |
|
|
2021
Q3 | $14.9M | Sell |
2,475,652
-944,225
| -28% | -$5.67M | 0.19% | 57 |
|
|
2021
Q2 | $16.7M | Sell |
3,419,877
-121,084
| -3% | -$590K | 0.19% | 54 |
|
|
2021
Q1 | $8.75M | Hold |
3,540,961
| – | – | 0.1% | 70 |
|
|
2020
Q4 | $9.7M | Buy |
3,540,961
+1,100,000
| +45% | +$3.01M | 0.1% | 68 |
|
|
2020
Q3 | $3.76M | Buy |
2,440,961
+503,353
| +26% | +$775K | 0.04% | 77 |
|
|
2020
Q2 | $3.64M | Sell |
1,937,608
-42,900
| -2% | -$80.7K | 0.05% | 71 |
|
|
2020
Q1 | $3.37M | Buy |
+1,980,508
| New | +$3.37M | 0.06% | 67 |
|